40834-96-6 ((prostaglandin F2alpha 15-methyl ether)

prostaglandin F2alpha 15-methyl ether;(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-methoxyoct-1-enyl]cyclopentyl]hept-5-enoic acid;ARE7BT6602;15-Methoxyprostaglandin F2alpha;Q27274081;SCHEMBL18532333;O-15-METHYLPROSTAGLANDIN F2.ALPHA. ETHER;O-15-Methylprostaglandin F2alpha ether;40834-96-6;Prosta-5,13-dien-1-oic acid, 9,11-dihydroxy-15-methoxy-, (5Z,9.alpha.,11.alpha.,13E,15S)-;Prostaglandin 15-methyl F2alpha;PDSP2_000737;Prosta-5,13-dien-1-oic acid, 9,11-dihydroxy-15-methoxy-, (5Z,9alpha,11alpha,13E,15S)-;PROSTAGLANDIN F2.ALPHA. 15-METHYL ETHER;UNII-ARE7BT6602;15-METHOXYPROSTAGLANDIN F2.ALPHA.;AGN-191995;(5Z,9I+/-,11I+/-,13E,15S)-9,11-Dihydroxy-15-methoxyprosta-5,13-dien-1-oic acid;AGN 191995;DTXSID601149162;Prostaglandin F2-alpha 15-methyl ether;Pgf2alpha 15-methyl ether;

RGZAEYWCXILWFX-NVRZHKMMSA-N

1S/C21H36O5/c1-3-4-7-10-16(26-2)13-14-18-17(19(22)15-20(18)23)11-8-5-6-9-12-21(24)25/h5,8,13-14,16-20,22-23H,3-4,6-7,9-12,15H2,1-2H3,(H,24,25)/b8-5-,14-13+/t16-,17+,18+,19-,20+/m0/s1

O[C@H]1C[C@H]([C@H](/C=C/[C@H](CCCCC)OC)[C@H]1C/C=C\CCCC(=O)O)O